Skip to main content

Summit Rock Advisors, LP

SEC CIK
0001540951
Latest filing
Aug 4, 2026

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Summit Rock Advisors, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overviewAll 13F holders of DYNFull Q2 2026 holdings

Shares (Q3 2022)
0
Sold out in Q3 2022
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q4 2021
Holdings of DYN by Summit Rock Advisors, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20220$00.0%−34,887−100.0%Sold outHolders
Q2 202234,887$240.0K0.2%00.0%UnchangedHolders
Q1 202234,887$336.0K0.2%00.0%UnchangedHolders
Q4 202134,887$415.0K0.2%+34,887NewHolders